Ubs Group Ag Myriad Genetics Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ubs Group Ag holds 203,959 shares of MYGN stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,959

Previous 121,887 67.33%

Holding current value

$3.12 Million

Previous $2.98 Million 87.25%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $1.97 Million - $2.35 Million	82,072 Added 67.33%	203,959 $5.58 Million
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $1.59 Million - $2.25 Million	-88,382 Reduced 42.03%	121,887 $2.98 Million
Q1 2024 May 13, 2024	BUY	$17.59 - $23.59 $729,158 - $977,876	41,453 Added 24.56%	210,269 $4.48 Million
Q4 2023 Feb 09, 2024	BUY	$13.91 - $21.32 $1.36 Million - $2.09 Million	98,056 Added 138.58%	168,816 $3.23 Million
Q3 2023 Nov 09, 2023	SELL	$15.99 - $23.22 $636,098 - $923,714	-39,781 Reduced 35.99%	70,760 $1.13 Million
Q2 2023 Aug 11, 2023	BUY	$17.56 - $23.76 $596,197 - $806,699	33,952 Added 44.33%	110,541 $2.56 Million
Q1 2023 May 12, 2023	SELL	$15.26 - $23.75 $1.64 Million - $2.55 Million	-107,464 Reduced 58.39%	76,589 $1.78 Million
Q4 2022 Feb 08, 2023	BUY	$14.51 - $20.99 $2.17 Million - $3.13 Million	149,281 Added 429.31%	184,053 $2.67 Million
Q3 2022 Nov 10, 2022	SELL	$18.21 - $27.88 $58,089 - $88,937	-3,190 Reduced 8.4%	34,772 $664,000
Q2 2022 Aug 10, 2022	SELL	$16.45 - $25.88 $1.69 Million - $2.66 Million	-102,877 Reduced 73.05%	37,962 $690,000
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $928,359 - $1.15 Million	-40,951 Reduced 22.53%	140,839 $3.55 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $1.98 Million - $2.68 Million	82,041 Added 82.25%	181,790 $5.02 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $2.64 Million - $3.23 Million	88,214 Added 764.75%	99,749 $3.22 Million
Q2 2021 Aug 13, 2021	SELL	$25.39 - $32.61 $2.44 Million - $3.13 Million	-95,989 Reduced 89.27%	11,535 $353,000
Q1 2021 May 12, 2021	BUY	$19.92 - $31.6 $404,814 - $642,175	20,322 Added 23.3%	107,524 $3.27 Million
Q4 2020 Feb 11, 2021	BUY	$12.16 - $19.77 $899,803 - $1.46 Million	73,997 Added 560.37%	87,202 $1.73 Million
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $52,593 - $68,956	4,675 Added 54.81%	13,205 $172,000
Q2 2020 Jul 31, 2020	SELL	$10.69 - $16.49 $283,937 - $437,990	-26,561 Reduced 75.69%	8,530 $97,000
Q1 2020 May 01, 2020	SELL	$9.78 - $29.53 $320,930 - $969,026	-32,815 Reduced 48.32%	35,091 $502,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $2.31 Million - $3.88 Million	-110,436 Reduced 61.92%	67,906 $1.85 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $3.51 Million - $7.48 Million	158,832 Added 814.11%	178,342 $5.11 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $22,624 - $34,930	998 Added 5.39%	19,510 $542,000
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $4.62 Million - $5.96 Million	-171,649 Reduced 90.27%	18,512 $615,000
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $4.66 Million - $7.79 Million	171,079 Added 896.55%	190,161 $5.53 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $93,060 - $124,692	-2,477 Reduced 11.49%	19,082 $878,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $3.46 Million - $5.01 Million	-124,777 Reduced 85.27%	21,559 $805,000
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $3.06 Million - $4.36 Million	106,258 Added 265.13%	146,336 $4.32 Million
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $70,356 - $91,847	2,473 Added 6.58%	40,078 $1.38 Million
Q3 2017 Nov 14, 2017	SELL	$24.01 - $36.2 $468,963 - $707,058	-19,532 Reduced 34.18%	37,605 $1.36 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-66,843 Reduced 53.91%	57,137 $1.48 Million
Q1 2017 Nov 14, 2017	BUY	N/A	123,980	123,980 $2.38 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account